Stephan C - Search Results

1

Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer.

Goltz D, Montani M, Braun M, Perner S, Wernert N, Jung K, Dietel M, Stephan C, Kristiansen G. Goltz D, et al. Among authors: stephan c. Pathology. 2015 Dec;47(7):629-36. doi: 10.1097/PAT.0000000000000320. Pathology. 2015. PMID: 26517642

2

Analytical performance and clinical validity of two free prostate-specific antigen assays compared.

Jung K, Stephan C, Lein M, Henke W, Schnorr D, Brux B, Schürenkämper P, Loening SA. Jung K, et al. Among authors: stephan c. Clin Chem. 1996 Jul;42(7):1026-33. Clin Chem. 1996. PMID: 8674185

3

The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.

Stephan C, Lein M, Jung K, Schnorr D, Loening SA. Stephan C, et al. Cancer. 1997 Jan 1;79(1):104-9. Cancer. 1997. PMID: 8988733

4

Elimination of serum free and total prostate-specific antigen after radical retropubic prostatectomy.

Lein M, Brux B, Jung K, Henke W, Koenig F, Stephan C, Schnorr D, Loening SA. Lein M, et al. Among authors: stephan c. Eur J Clin Chem Clin Biochem. 1997 Aug;35(8):591-5. doi: 10.1515/cclm.1997.35.8.591. Eur J Clin Chem Clin Biochem. 1997. PMID: 9298348

5

Relation of free PSA/total PSA in serum for differentiating between patients with prostatic cancer and benign hyperplasia of the prostate: which cutoff should be used?

Lein M, Stephan C, Jung K, Schnorr D, Loening S. Lein M, et al. Among authors: stephan c. Cancer Invest. 1998;16(1):45-9. doi: 10.3109/07357909809039753. Cancer Invest. 1998. PMID: 9474251 Review.

6

ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: proof of new complex forming of PSA after release into circulation.

Stephan C, Jung K, Brux B, Lein M, Sinha P, Schnorr D, Loening SA. Stephan C, et al. Urology. 2000 Apr;55(4):560-3. doi: 10.1016/s0090-4295(99)00548-8. Urology. 2000. PMID: 10736503

7

Elimination of serum complexed prostate-specific antigen after radical retropubic prostatectomy.

Stephan C, Jung K, Brux B, Lein M, Sinha P, Schnorr D, Loening SA. Stephan C, et al. Clin Chem Lab Med. 2000 Apr;38(4):309-11. doi: 10.1515/CCLM.2000.044. Clin Chem Lab Med. 2000. PMID: 10928650

8

[Molecular forms of prostate-specific antigen and human kallikrein 2 as possible indicators in prostatic carcinoma diagnosis].

Lein M, Stephan C, Jung K, Schnorr D, Loening SA. Lein M, et al. Among authors: stephan c. Urologe A. 2000 Jul;39(4):313-23. doi: 10.1007/s001200050363. Urologe A. 2000. PMID: 10957772 Review. German.

9

Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue.

Magklara A, Scorilas A, Stephan C, Kristiansen GO, Hauptmann S, Jung K, Diamandis EP. Magklara A, et al. Among authors: stephan c. Urology. 2000 Sep 1;56(3):527-32. doi: 10.1016/s0090-4295(00)00621-x. Urology. 2000. PMID: 10962338

10

Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer.

Stephan C, Jung K, Lein M, Sinha P, Schnorr D, Loening SA. Stephan C, et al. Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1133-47. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11097220 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

949 results

Search Page

Filters